Journal article

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Lucy C Fox, Katherine D Cummins, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt Show all

Blood Advances | AMER SOC HEMATOLOGY | Published : 2017


Funding Acknowledgements

J.S. and D.Y. have received honoraria from Novartis and Bristol-Myers Squibb (BMS) and research funding from BMS and participated in Advisory Boards for Novartis. S.F. has received honoraria from BMS and research funding from BMSand participated in Advisory Boards for Ariad. C.F. has received a travel grant from BMS. A.G. has participated in Advisory Boards for Novartis and BMS. The remaining authors declare no competing financial interests.